Across TCGA pan-cancer cohorts, LARP4B RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated LARP4B data layer compared with 6 for mutation status and 5 for mass-spec protein.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LARP4B RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LARP4B expression acts as an unfavorable survival marker, although some lineages such as LGG and HNSC show a favorable association.
ACC, LIHC, and CESC are the cancer types where LARP4B RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.